WINDTREE THERAPEUTICS INC /DE/ Financing Cash Flow
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Financing Cash Flow of $15.83 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $7.06M, a 1.76% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $6.97M, a 337.20% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $1.80M, a 74.18% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $3.16M, a 507.29% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for fiscal 2024 was $12.73M, a 9.81% increase from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for fiscal 2023 was $11.60M, a 276.58% increase from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for fiscal 2022 was $3.08M, a 89.51% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) financing activities for fiscal 2021 was $29.36M, a 47.11% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $7.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $14.03M derived: sum of 2 quarters · filed 2025-11-19 | $15.83M 10-Q · filed 2025-11-19 | $19.00M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2025-06-30 | $6.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $8.77M 10-Q · filed 2025-08-19 | $11.93M derived: sum of 3 quarters · filed 2025-08-19 | $18.88M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-15 | $4.96M derived: sum of 2 quarters · filed 2025-05-15 | $11.91M derived: sum of 3 quarters · filed 2025-11-19 | $13.50M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $10.11M derived: sum of 2 quarters · filed 2025-11-19 | $11.70M derived: sum of 3 quarters · filed 2025-11-19 | $12.73M 10-K · filed 2025-04-15 | |
| 2024-09-30 | $6.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $8.54M derived: sum of 2 quarters · filed 2025-11-19 | $9.57M 10-Q · filed 2025-11-19 | $10.09M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $2.63M 10-Q · filed 2025-08-19 | $3.15M derived: sum of 3 quarters · filed 2025-08-19 | $2.92M derived: sum of 4 quarters · filed 2025-08-19 | |
| 2024-03-31 | $1.03M 10-Q · filed 2025-05-15 | $1.55M derived: sum of 2 quarters · filed 2025-05-15 | $1.32M derived: sum of 3 quarters · filed 2025-05-15 | $12.04M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $288.00K derived: sum of 2 quarters · filed 2025-04-15 | $11.00M derived: sum of 3 quarters · filed 2025-04-15 | $11.60M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $10.48M derived: sum of 2 quarters · filed 2024-11-26 | $11.07M 10-Q · filed 2024-11-26 | $12.19M derived: sum of 4 quarters · filed 2024-11-26 | |
| 2023-06-30 | $10.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $11.31M 10-Q · filed 2024-08-19 | $12.42M derived: sum of 3 quarters · filed 2024-08-19 | $13.58M derived: sum of 4 quarters · filed 2024-08-19 | |
| 2023-03-31 | $591.00K 10-Q · filed 2024-05-15 | $1.71M derived: sum of 2 quarters · filed 2024-05-15 | $2.86M derived: sum of 3 quarters · filed 2024-05-15 | $3.76M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $2.27M derived: sum of 2 quarters · filed 2024-04-16 | $3.17M derived: sum of 3 quarters · filed 2024-04-16 | $3.08M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.05M derived: sum of 2 quarters · filed 2023-11-09 | $1.96M 10-Q · filed 2023-11-09 | $4.88M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $806.00K 10-Q · filed 2023-08-07 | $3.72M derived: sum of 3 quarters · filed 2023-08-07 | $3.68M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | -$89.00K 10-Q · filed 2023-05-15 | $2.82M derived: sum of 2 quarters · filed 2023-05-15 | $2.78M derived: sum of 3 quarters · filed 2023-05-15 | $1.66M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.87M derived: sum of 2 quarters · filed 2023-03-31 | $1.75M derived: sum of 3 quarters · filed 2023-03-31 | $29.36M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.16M derived: sum of 2 quarters · filed 2022-11-14 | $26.45M 10-Q · filed 2022-11-14 | $26.50M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $26.49M 10-Q · filed 2022-08-11 | $26.54M derived: sum of 3 quarters · filed 2022-08-11 | $25.40M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $27.61M 10-Q · filed 2022-05-05 | $27.66M derived: sum of 2 quarters · filed 2022-05-05 | $26.52M derived: sum of 3 quarters · filed 2022-05-05 | $47.77M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.09M derived: sum of 2 quarters · filed 2022-03-31 | $20.16M derived: sum of 3 quarters · filed 2022-03-31 | $19.96M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $20.11M derived: sum of 2 quarters · filed 2021-11-10 | $19.91M 10-Q · filed 2021-11-10 | $42.65M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $21.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $21.05M 10-Q · filed 2021-08-05 | $43.79M derived: sum of 3 quarters · filed 2021-08-05 | $43.44M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$199.00K 10-Q · filed 2021-05-13 | $22.54M derived: sum of 2 quarters · filed 2021-05-13 | $22.19M derived: sum of 3 quarters · filed 2021-05-13 | $22.17M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $22.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $22.39M derived: sum of 2 quarters · filed 2021-03-29 | $22.37M derived: sum of 3 quarters · filed 2021-03-29 | $21.77M 10-K · filed 2021-03-29 | |
| 2019-09-30 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$373.00K derived: sum of 2 quarters · filed 2020-11-16 | -$971.00K 10-Q · filed 2020-11-16 | $29.45M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$625.00K 10-Q · filed 2020-08-14 | $29.79M derived: sum of 3 quarters · filed 2020-08-14 | $33.07M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$598.00K 10-Q · filed 2020-05-13 | $29.82M derived: sum of 2 quarters · filed 2020-05-13 | $33.10M derived: sum of 3 quarters · filed 2020-05-13 | $35.64M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $30.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $33.70M derived: sum of 2 quarters · filed 2020-04-03 | $36.24M derived: sum of 3 quarters · filed 2020-04-03 | $38.74M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.82M derived: sum of 2 quarters · filed 2019-11-14 | $8.32M 10-Q · filed 2019-11-14 | $13.19M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.04M 10-Q · filed 2019-08-14 | $5.04M 10-Q · filed 2018-08-14 | $9.91M derived: sum of 3 quarters · filed 2019-08-14 | $12.51M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $2.50M 10-Q · filed 2019-05-20 | $7.37M derived: sum of 2 quarters · filed 2019-05-20 | $9.97M derived: sum of 3 quarters · filed 2019-05-20 | $10.01M derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | $4.87M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | $7.47M derived: sum of 2 quarters · filed 2019-04-23 | $7.51M derived: sum of 3 quarters · filed 2019-04-23 | $17.30M 10-K/A · filed 2019-04-23 | |
| 2017-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $2.64M derived: sum of 2 quarters · filed 2018-11-14 | $12.43M 10-Q · filed 2018-11-14 | $12.66M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $9.82M 10-Q · filed 2018-08-14 | $10.06M derived: sum of 3 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $9.79M 10-Q · filed 2018-05-21 | $10.02M derived: sum of 2 quarters · filed 2018-05-21 | |||
| 2016-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $709.00K 10-K · filed 2018-04-17 | |||
| 2016-09-30 | $471.00K 10-Q · filed 2017-11-14 | ||||
| 2014-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$37.00K derived: sum of 2 quarters · filed 2014-11-07 | $398.00K 10-Q · filed 2014-11-07 | $75.94M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2014-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $415.00K 10-Q · filed 2014-08-07 | $75.96M derived: sum of 3 quarters · filed 2014-08-07 | $75.94M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2014-03-31 | $435.00K 10-Q · filed 2014-05-12 | $75.98M derived: sum of 2 quarters · filed 2014-05-12 | $75.96M derived: sum of 3 quarters · filed 2014-11-07 | $91.06M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-12-31 | $75.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $75.53M derived: sum of 2 quarters · filed 2014-11-07 | $90.62M derived: sum of 3 quarters · filed 2014-11-07 | $100.45M 10-K · filed 2014-03-17 | |
| 2013-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $15.08M derived: sum of 2 quarters · filed 2014-11-07 | $24.91M 10-Q · filed 2014-11-07 | $24.84M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-06-30 | $15.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $24.92M 10-Q · filed 2014-08-07 | $24.86M derived: sum of 3 quarters · filed 2014-08-07 | $24.84M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $9.83M 10-Q · filed 2014-05-12 | $9.77M derived: sum of 2 quarters · filed 2014-05-12 | $9.75M derived: sum of 3 quarters · filed 2014-05-12 | $9.76M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$84.00K derived: sum of 2 quarters · filed 2014-03-17 | -$74.00K derived: sum of 3 quarters · filed 2014-03-17 | $50.22M 10-K · filed 2014-03-17 | |
| 2012-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$8.00K derived: sum of 2 quarters · filed 2013-11-12 | $50.29M 10-Q · filed 2013-11-12 | $50.61M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $50.31M 10-Q · filed 2013-08-08 | $50.63M derived: sum of 3 quarters · filed 2014-03-17 | $50.59M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-03-31 | $50.30M 10-Q · filed 2013-05-07 | $50.62M derived: sum of 2 quarters · filed 2014-03-17 | $50.58M derived: sum of 3 quarters · filed 2014-03-17 | $50.53M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2011-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $283.00K derived: sum of 2 quarters · filed 2014-03-17 | $236.00K derived: sum of 3 quarters · filed 2014-03-17 | $22.78M 10-K · filed 2014-03-17 | |
| 2011-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$84.00K derived: sum of 2 quarters · filed 2012-11-14 | $22.46M 10-Q · filed 2012-11-14 | $23.63M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $22.50M 10-Q · filed 2012-08-14 | $23.66M derived: sum of 3 quarters · filed 2013-03-15 | $19.97M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-03-31 | $22.55M 10-Q · filed 2012-05-15 | $23.71M derived: sum of 2 quarters · filed 2013-03-15 | $20.02M derived: sum of 3 quarters · filed 2013-03-15 | ||
| 2010-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$2.53M derived: sum of 2 quarters · filed 2013-03-15 | $18.84M 10-K · filed 2013-03-15 | ||
| 2010-09-30 | -$3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $17.68M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $21.37M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |